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Abstract
Background: The aim was to test the hypothesis that the blood serum of rats subjected to recurrent airway 
obstructions mimicking obstructive sleep apnea (OSA) induces early activation of bone marrow-derived mesenchymal 
stem cells (MSC) and enhancement of endothelial wound healing.
Methods: We studied 30 control rats and 30 rats subjected to recurrent obstructive apneas (60 per hour, lasting 15 s 
each, for 5 h). The migration induced in MSC by apneic serum was measured by transwell assays. MSC-endothelial 
adhesion induced by apneic serum was assessed by incubating fluorescent-labelled MSC on monolayers of cultured 
endothelial cells from rat aorta. A wound healing assay was used to investigate the effect of apneic serum on 
endothelial repair.
Results: Apneic serum showed significant increase in chemotaxis in MSC when compared with control serum: the 
normalized chemotaxis indices were 2.20 ± 0.58 (m ± SE) and 1.00 ± 0.26, respectively (p < 0.05). MSC adhesion to 
endothelial cells was greater (1.75 ± 0.14 -fold; p < 0.01) in apneic serum than in control serum. When compared with 
control serum, apneic serum significantly increased endothelial wound healing (2.01 ± 0.24 -fold; p < 0.05).
Conclusions: The early increases induced by recurrent obstructive apneas in MSC migration, adhesion and endothelial 
repair suggest that these mechanisms play a role in the physiological response to the challenges associated to OSA.
Background
Obstructive sleep apnea (OSA) is a prevalent disease
affecting both children and adults. This sleep breathing
disorder, caused by an abnormal increase in upper airway
collapsibility, is characterized by recurrent events of air-
way obstruction, each finishing with the patient's uncon-
scious arousal. These repetitive respiratory disturbances,
which could appear more than once every minute in
patients with severe OSA, induce increases in sympa-
thetic activation, large negative intrathoracic pressure
swings, hypoxia/reoxygenation events and disruption of
sleep architecture. Extensive data in the literature prove
that, in addition to immediate symptoms such as abnor-
mal diurnal somnolence, OSA increases the mid- and
long-term risk of metabolic dysfunctions and cardiovas-
cular diseases [1,2]. Systemic inflammation and endothe-
lial dysfunction triggered by recurrent hypoxia/
reoxygenation have proved to be relevant processes as
regards determining the consequences of OSA [3-5]. The
susceptibility of distinct OSA patients to these conse-
quences would, however, depend on the effectiveness of
the individual homeostatic response to the challenges
posed by the syndrome.
The main physiological response to the intermittent
hypoxia and increased inspiratory efforts characteristic of
OSA consists of the upregulation of well known signalling
cascades that counteract oxidative stress and inflamma-
tion. Interestingly, data recently published on diseases
distinct from OSA suggest that bone marrow-derived
mesenchymal stem cells (MSC) circulating in peripheral
blood could also contribute to the homeostatic response
in OSA. Indeed, it has been shown that these stem cells
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Page 2 of 7play anti-inflammatory, anti-oxidative stress and
endothelium-repairing roles via paracrine secretion of
soluble factors [6,7]. The recent finding that the number
of circulating MSC was acutely increased in a rat model
of recurrent obstructive apneas [8] adds support to the
hypothesis that MSC could be involved in the response to
the injurious stimuli in OSA. In order to shed light on the
potential role of MSC in this sleep breathing disorder, this
study sought to investigate whether the blood serum of
rats subjected to recurrent obstructive apneas mimicking
OSA modulates basic mechanisms in the response to
inflammation and endothelial damage: MSC migration
and adhesion to endothelial cells and endothelial wound
healing.
Methods
Application of recurrent obstructive apneas simulating 
OSA
This animal study was approved by the Ethical Commit-
tee for Animal Research of the University of Barcelona.
Sixty Sprague-Dawley male rats (250-300 g) were intrap-
eritoneally anaesthetized with urethane (1 mg/kg). Thirty
rats were used as controls and 30 rats were subjected to
recurrent airway obstructions at a rate of 60 apneas/hour
for 5 hours, with each apnea lasting 15 seconds. The
obstructive apneas were non-invasively applied by means
of an electronically controlled nasal mask system recently
described in detail by our group [8]. Arterial oxygen satu-
ration was monitored by a pulse oxymeter (504; Critical
Care Systems, Inc., Waukesha, WI) placed at the rat leg
(Figure 1). After 5 h of recurrent obstructive apneas, 10-
12 mL of blood from the carotid artery were collected in a
serum separator gel tube and the rat was sacrificed by
exsanguination. The serum was separated by centrifuga-
tion (1800 rpm, 20 min, room temperature) and frozen (-
20°C) in aliquots for subsequent use. The sera of the 30
apneic rats and 30 control rats were randomly distributed
for three different assays: migration, adhesion and wound
healing assays using rat MSC and primary rat endothelial
cells (10 apneic and 10 control rats for each assay).
Mesenchymal stem cells
The study was performed on well-characterized Lewis rat
marrow stromal cells kindly provided by Tulane Center
for Gene Therapy [9]. Cells were cultured in MEM-alpha
medium with L-glutamine and without ribonucleosides
or deoxyribonucleosides (GIBCO, Gaithersburg, MD)
supplemented with 20% fetal bovine serum (FBS;
HyClone Cell Culture), 1% antibiotic-antimycotic (con-
taining 10000 U/ml Penicillin G sodium, 10000 μg/ml
Streptomycin sulfate, 25 μg/ml Amphotericin B as Fungi-
zone in 0.85% saline (GIBCO, Gaithersburg, MD) and 2%
L-glutamine (200 mM in 0.85% NaCl (GIBCO, Gaithers-
burg, MD). Cells were grown in an incubator (37°C, 5%
CO2, 100% humidity). Subconfluent cells were dissoci-
ated with 0.25% trypsin and 1 mM Ethylene Diamine Tet-
raacetic Acid (EDTA) in Hanks' Balanced Salt Solution
(GIBCO, Gaithersburg, MD) and subcultured at low den-
sity in new culture flasks. The differentiation potential of
the MSC employed in this study was tested by culturing
them in conventional adipogenic and osteogenic media
for 21 days [8]. Positive differentiation into adipocytes
and osteocytes was confirmed by staining the cells with
Oil Red O and Alizarin Red S, respectively [8].
Endothelial cell culture
Endothelial cell monolayers were obtained from anesthe-
tized rats sacrificed by exsanguination through the
carotid artery. A 2-cm long section of thoracic aorta was
isolated and rinsed several times with Dulbecco's Phos-
phate Buffered Saline (DPBS) (Gibco™, Invitrogen, Carls-
bad, CA, USA). The luminal artery surface was exposed
to isolate the endothelial cells by incubation with collage-
nase II solution (1 mg/mL) (Gibco™, Invitrogen, Carlsbad,
CA, USA) (37°C, 1 h) and centrifugation (1600 rpm, 10
min). After discarding the supernatant, cells were washed
with DPBS and re-suspended in Dulbecco's modified
Eagle's medium (DMEM) containing 1% (wt/vol) glucose
(Gibco™, Invitrogen, Carlsbad, CA, USA), 10% inactivated
fetal bovine serum (FBS) (Gibco™, Invitrogen, Carlsbad,
CA, USA) and 0.5% antibiotics solution (streptomycin/
penicillin solution 10,000U/ml) (Sigma Chemical Co., St.
Louis, MO). Endothelial cells were cultured (37°C, 5%
CO2, 100% humidity) by replacing the medium every 2-3
days until a cell monolayer was obtained (8-10 days).
MSC migration assay
The chemotaxis and chemokinesis induced in MSC by
the serum from control rats and from rats subjected to
apneas (apneic serum) were assessed by inducing cell
migration through the permeable membrane of tran-
swells (6.5 membrane diameter, 8.0 μm pore filters; Corn-
Figure 1 Example of arterial blood oxygen saturation (SaO2) re-
corded in a rat during the application of recurrent airway ob-
structions. The amplitude and time course of desaturations mimicked 
those typically observed in patients with obstructive sleep apnea.
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Page 3 of 7ing Costar, Cambridge, MA). The upper side of the
transwell membrane was coated with 0.1% (wt/vol)
bovine gelatin (Sigma Chemical Co., St. Louis, MO) in
DPBS for 1 h at 37°C. A suspension of 1.5 × 105 MSC in
190 μL of serum was placed in the upper compartment of
the transwell and 1 ml of serum was placed in the lower
compartment. The sera from 10 rats subjected to apneas
and 10 control rats were used. Three transwell measure-
ments were carried out for each pair of rat sera (apneic
and control): 1) control serum in both the upper and
lower compartment of the transwell (Control/Control), 2)
apneic serum in both the upper and lower compartment
of the membrane (Apnea/Apnea), and 3) apneic serum
and control serum in the upper and lower transwell com-
partments, respectively (Apnea/Control). After 8 h of
incubation of the transwell plates (5% CO2 at 37°C, 100%
humidity), the upper side of the membrane was washed
with cold DPBS. Using a cotton wool swab, the MSC
remaining on the upper face of the membrane were
removed and the cells on the lower side of the membrane
were stained (May-Grünwald-Giemsa). The membrane
was cut out with a scalpel, with the edges discarded,
before being mounted on a micro slide glass, with the
lower side on the top, and the image was digitized and
stored (Eclipse TE2000-E, Nikkon; MetaMorph 7.6.1.0
software). The number of cells that migrated to the lower
side of the membrane was counted by means of light
microscopy, operated by an investigator who was blind to
the types of sera present in each preparation. A normal-
ized chemokinesis index was computed by dividing the
number of cells counted in the Apnea/Apnea transwells
by the number of cells counted in the Control/Control
transwells. Similarly, a normalized chemotaxis index was
computed by dividing the number of cells counted in the
Apnea/Control transwells by the number of cells counted
in the Control/Control transwells.
MSC-endothelial adhesion assay
To assess the adhesion of MSC to endothelial cells when
pretreated with control or apneic sera, they were first flu-
orescent-labelled with Vybrant CM-DiI (Gibco, Invitro-
gen, Carlsbad, CA, USA) at 6 μM for 20 min at 37°C and
15 min at 4°C (5% CO2, 100% humidity) and then washed
with DPBS and re-suspended with complete medium.
After labelling, MSC were pre-treated overnight with
serum from 10 control rats or serum from 10 apneic rats
and subsequently incubated on the endothelial cell
monolayer for 6 h. The monolayer was then washed with
medium and a fluorescent image was digitized and stored
(Eclipse TE2000-E, Nikkon; MetaMorph 7.6.1.0 soft-
ware). The MSC that remained adhered to the endothe-
lial cells were counted by an investigator who was blind to
the type of serum in each preparation. A normalized
adhesion index was computed by dividing the number of
cells counted by the mean value of counted cells in con-
trols.
Endothelial wound healing assay
A wound healing assay was used to investigate the effects
of apneic serum on the repair of aortic endothelial cell
monolayers. Briefly, 4 × 104 endothelial cells/well were
seeded into 24-well plates and incubated (37°C, 5% CO2,
100% humidity) until they reached confluence. The
endothelial cell monolayer of each well was scratch-
wounded using a sterile 2-200 μL pipette tip (Eppendorf
AG, Hamburg, Germany) and the debris was removed by
washing with DPBS (Dulbecco's Phosphate Buffered
Saline 1 × [-] CaCl2, [-] MgCl2; Gibco, Invitrogen, Carls-
bad, CA, USA). The washing medium was subsequently
removed and 300 μL/well of rat serum were used as the
culture medium for the wounded endothelial monolay-
ers. The well plate was then placed on the motorized
stage of a microscope (Eclipse Ti, Nikon) equipped with a
CCD camera (C9100, Hamamatsu) driven by Meta-
Morph 7.6.1.0 software. A microscope incubator (Life
Imaging Services) maintained the whole system at 37°C,
5% CO2 and 100% humidity throughout the experiment.
The endothelial wound healing process was assessed by
automatically recording phase-contrast images of each
well every 10 min from the beginning of the experiment
up to 24 h of incubation. This wound healing assay was
carried out using serum from 10 control rats and 10
apneic rats, in both cases with and without precondition-
ing the serum with MSC. Accordingly, a total of 40 wells
were studied: non-conditioned serum and MSC-condi-
tioned serum from each of the 10 apneic rats and 10 con-
trol rats. MSC-conditioned serum was obtained by
culturing confluent MSC with rat serum for 48 h (24-well
plate, 300 μL/well). At the end of the experiments, an
investigator blind to the type of serum used in each well
computed a wound closure index by comparing the initial
and final (24 h) images of the endothelial wound. Meta-
Morph software was used to identify the initial and final
limits of the wound. The closure index was computed as
the increase in the wound's endothelial area, normalized
to the mean increase in the case of the control serum.
Statistical analysis
Data are presented as mean ± SEM. Comparisons
between the different groups were carried out by means
of the Student's t-test (when applicable) or the Mann-
Whitney test. Statistical significance was established as p
< 0.05.
Results
The serum of apneic rats increased the motility of MSC.
As shown by the examples of transwell membrane images
in Figure 2 (top), more cells migrated in the Apnea/Con-
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bottom panel of this figure shows that the chemotaxis
index for the serum of the apneic rats (2.20 ± 0.58) was
significantly higher than that for the control serum (1.00
± 0.26; p < 0.05). In contrast, the increase observed in the
chemokinesis index when comparing the serum from
apneic rats and the control serum was not statistically sig-
nificant.
MSC exhibited significantly more adhesion to the
monolayer of cultured endothelial cells when incubated
in apneic rat serum as compared to control rat serum.
Figure 3 (top) illustrates that more labelled-MSC adhered
to the endothelial monolayer in the case of the apneic
serum. This figure's bottom panel shows that the MSC-
endothelial adhesion index was significantly higher in
apneic serum than in control serum: 1.75 ± 0.14 and 1.00
± 0.06, respectively (p < 0.01).
As shown in Figure 4, endothelial wound healing was
significantly increased when the injured monolayer was
cultured with serum from rats subjected to recurrent
apneas as compared with culture in control serum (2.01 ±
0.24 vs 1.00 ± 0.34; p < 0.05). Fig. 4 also shows that pre-
conditioning the control and apneic rat sera with MSC
resulted in an increase in the endothelial wound closure
index (3.11 ± 0.39 and 2.99 ± 0.41, respectively; p < 0.01
in both cases).
Discussion
In this work we have assessed whether MSC could play a
role in the physiological response to the injurious stimuli
that characterize OSA and cause the cardiovascular con-
sequences of this sleep breathing disorder. We focused
our attention on basic mechanisms that potentially con-
tribute to the repair of endothelial damage. The results
obtained in this acute animal model study show that
short-term recurrent obstructive apneas mimicking OSA
triggered an early activation of MSC: specifically, an
increase in the mobility of these stem cells and in their
adhesion to endothelial cells. Moreover, it was also found
that the serum of apneic rats improved endothelial
Figure 2 Top: Examples of the fields of view of transwell mem-
branes, showing the stained MSC cells that migrated to the lower 
membrane side of transwells when the upper compartment con-
tained control serum (left) and serum from rats subjected to re-
current obstructive apneas (right). Serum of control rats was placed 
in the lower transwell compartment in both cases. Bottom: Normalized 
indices for the migration of mesenchymal stem cells induced by the 
serum of control and apneic rats. Data are mean ± SEM. NS: non-signif-
icant (p > 0.05).
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Figure 3 Top: Examples of fields of view of the fluorescence-la-
belled MSC adhered to cultured endothelial cells when incubated 
in control serum (left) and in serum from rats subjected to recur-
rent obstructive apneas (right). Bottom: Normalized index for the ad-
hesion of MSC to endothelial cells in control rat serum and in serum 
from rats subjected to recurrent obstructive apneas. Data are mean ± 
SEM.
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enhanced repair.
The potential protective or therapeutic role of MSC in
various human diseases [10] and animal models has been
extensively investigated for non-respiratory diseases [11-
13], as well as for several respiratory pathologies [14-17].
It has been proven that, in addition to their capacity for
tissue regeneration by homing at the injured tissue and
differentiating onto damaged cell phenotypes, MSC
secrete soluble mediators which can immuno-modulate
inflammation and anti-oxidative cascades improving
repair of vascular endothelium [6,7]. Only a very few
studies, however, have focused on the potential role of
stem cells in OSA, although there have been recent
reports of the detection of circulating endothelial progen-
itor cells in patients [18-20] and circulating MSC in a rat
model [8]. Accordingly, to our knowledge this is the first
work studying how the stimuli characterizing OSA acti-
vate MSC responses and thus potentially contribute to
the response to inflammation and the enhancement of
vascular repair.
The methods used in the present study consisted of an
in vivo rat model to obtain serum from control rats and
from rats subjected to apneas and in vitro techniques to
compare the effects of these sera on MSC and endothelial
cell properties. One advantage of the animal model used
in this study is that by non-invasively applying recurrent
obstructive apneas in healthy animals the rats were sub-
jected to periodic stimuli very similar (in magnitude,
duration and frequency) to the ones experienced by
patients with OSA: strenuous breathing efforts against a
closed airway and hypoxemic events [21,22]. This acute
model allowed us to study the early effects of these injuri-
ous stimuli while avoiding other confounding factors
found in OSA patients that also cause inflammation and
endothelial dysfunction (metabolic syndrome, obesity,
hypertension, etc) [1-5]. The methodology employed in
this short-term study may be also useful to investigate the
chronic effects of long-term recurrent obstructive apneas
in a chronic animal model [21]. Specifically, to investigate
potential adaptation mechanisms in response to a long-
term challenge as in OSA patients and to study the role of
endothelial progenitor cells in vascular repair. The in
vitro methodology used to investigate the effects of con-
trol and apneic rat sera on MSC and endothelial cells is
widely reported in the literature. Indeed, the transwell
setting for assessing chemotaxis and chemokinesis has
previously been used to study MSC migration in response
to different biochemical stimuli [23] and the fluorescent-
staining method employed for assessing the adhesion of
MSC to endothelial cell monolayers has been used in
both in vivo and in vitro studies [24]. Moreover, the
endothelial wound healing assay used in the present study
is frequently encountered in research on endothelial
repair mechanisms in vitro [25,26]. Interestingly, these in
vitro methods are readily applicable in future studies to
investigate whether the serum of OSA patients, before
and after CPAP therapy, activates MSC and enhances
endothelial repair when compared with serum from
healthy controls.
Our experimental setting was designed to assess the
early effects on MSC and endothelial cells induced by the
serum of rats subjected to recurrent airway obstructions.
Accordingly, the changes observed in migration, adhe-
sion and wound healing were exclusively caused by the
soluble factors released into the animals' serum as a result
of subjecting them to the breathing stimulus mimicking
OSA. This approach allowed us to identify the effects of
soluble factors in blood from the effects of the other
potentially important stimuli also experienced by these
cells in OSA patients, such as intermittent hypoxia due to
the recurrent changes in arterial oxygen saturation. The
specific effects of intermittent hypoxia on cultured MSC
Figure 4 Top: Images of a representative example of an endothe-
lial wound healing test showing the wound at the beginning of 
the experiment (left) and 24 h after the culture medium was re-
placed by apneic rat serum (right). Red and yellow lines indicate the 
initial and final wound borders. Bottom: Normalized index for wound 
closure when the endothelial cells were cultured in medium consist-
ing of serum of control rats and of rats subjected to recurrent obstruc-
tive apneas, with or without preconditioning with MSC. Data are mean 
± SEM.
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given the technical difficulty of adequately applying, at
the cell level, the high-rate of oxygen pressure changes
mimicking OSA [27]. As regards the design of this study,
it should also be pointed out that the experiments to
assess the effects of rat serum on MSC-endothelial adhe-
sion and on endothelial wound healing did not allow us to
differentiate between the specific serum effects on each
type of cell separately. This limitation does not, however,
affect the aim of this study as these two types of cells are
simultaneously exposed to the same blood serum in
patients.
The blood serum of rats acutely subjected to recurrent
obstructive apneas was chemoattractant for MSC (Figure
2). This could explain the finding in a previous study on a
similar rat model that the number of MSC circulating in
peripheral blood increased in apneic rats when compared
with controls [8]. Accordingly, the soluble factors
released into the serum as a rat's physiological response
to the obstructive stimulus would be sensed by the MSC
in the bone marrow (and in other tissues which are also
reservoirs of these cells) and would induce their mobiliza-
tion from their original niche to the bloodstream. In fact,
this interpretation is consistent with the generally
accepted hypothesis that a gradient of soluble factors
secreted into the bloodstream is one of the mechanisms
by which injured tissue induces the mobilization and
recruitment of MSC. Although the exact mechanism trig-
gering MSC mobilization is not known in detail, there is
evidence to suggest that various growth factors and
inflammatory cytokines characterizing inflammation in
OSA (e.g. IL1-β and TNF-α) contribute to MSC migra-
tion [23].
Once released into the blood, circulating MSC migrate
and home at the injured organ via a dynamic process sim-
ilar to that of neutrophils in response to inflammation
[28]: transient adhesion to endothelial cells, rolling, firm
adhesion to the endothelium and transmigration into the
tissues where MSC participate in the repair of the dam-
aged tissue [29]. The enhancement observed in the adhe-
sion of MSC on to endothelial cells (Figure 3) when
cultured with apneic serum could be caused by the higher
levels of pro-inflammatory cytokines in apneic serum.
Effectively, IL1-β and TNF-α, which increase in the
serum of animals in OSA models and in that of patients
with this sleep disorder, have proved to increase the adhe-
sion of MSC to cardiac endothelial cells both in vivo and
in vitro [24]. Increased MSC-endothelial adhesion,
together with the increase in MSC migration capacity
(Figure 2) observed when mesenchymal stem cells were
acutely exposed to the serum of rats subjected to recur-
rent apneas, suggests that OSA could facilitate a crucial
step in tissue repair: the homing of MSC on the endothe-
lium and injured sub-endothelial tissues.
A remarkable finding in this study was that, when com-
pared with controls, the serum of rats subjected to recur-
rent obstructive apneas enhanced the wound closure of
endothelial cell monolayers (Figure 4). Accordingly, the
injurious stimuli in OSA (namely, intermittent hypoxia
and strenuous breathing) would also trigger a response to
enhance the repair of the injured endothelium. Whereas
most of the published literature on vascular dysfunction
in OSA is focused on the deleterious effects caused by
blood soluble factors on the endothelium, little is known
about the potential repair mechanisms triggered by inju-
rious OSA stimuli. As endothelial wound healing is
strongly enhanced by vascular endothelial growth factor
(VEGF) [26] and the stimulus of OSA promotes an
increase in blood VEGF [18], the observed increase in
wound closure when culturing endothelial cells with
apneic serum could be attributed to VEGF. In this
respect, it is interesting to note that one potential source
of the VEGF in the blood of apneic rats could be the cir-
culating MSC induced by recurrent obstructive apneas
[8]. Indeed, it has been shown that MSC express VEGF in
response to a hypoxic stimulus [25]. It should be noted,
however, that, regardless of the specific potential role of
VEGF, MSC per se secrete factors that promote endothe-
lial repair [30]. In line with this interpretation, we found
that acutely preconditioning rat serum with MSC was
sufficient to increase wound closure in both apneic and
control sera (Figure 4). The fact that this increase was
higher when the sera were preconditioned with MSC
than when using apneic serum with no MSC precondi-
tioning could be explained by the fact that the concentra-
tion of MSC in MSC-preconditioned sera was lower than
in the circulating blood of apneic rats [8].
Conclusions
This animal model study suggests that bone marrow-
derived MSC could play a role in the physiological
response to counterbalance the pro-inflammatory, oxida-
tive stress and endothelial dysfunction mechanisms that
lead to the middle- and long-term consequences of OSA.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
The conception and scientific direction of this work was undertaken by RF. Ani-
mal experimentation was carried out by AC and TS. Data processing and statis-
tical analysis was undertaken by AC, TS, and JMM. AC, MR, TS, JMM, and DN
participated in the discussion of the results and contributed to the manuscript
draft. All authors read and gave critical input to this manuscript.
Acknowledgements
The authors wish to thank the Tulane Center for Gene Therapy (Dr. D. Prockop) 
for kindly providing the rat mesenchymal stem cells used in this study. The 
authors are grateful to Dr. Isaac Almendros for his help in implementing the rat 
model of obstructive apneas and to Ms. Rocío Nieto and Mr. Miguel A. 
Rodríguez for their excellent technical assistance. This work was supported in 
part by the Ministerio de Ciencia e Innovación (SAF2008-02991 and PI08/0277).
Carreras et al. Respiratory Research 2010, 11:91
http://respiratory-research.com/content/11/1/91
Page 7 of 7Author Details
1Unitat de Biofísica i Bioenginyeria, Facultat de Medicina, Universitat de 
Barcelona -IDIBAPS, Barcelona, Spain, 2CIBER Enfermedades Respiratorias, 
Bunyola, Spain, 3Division of Pulmonary, Allergy and Critical Care Medicine, 
Department of Medicine, Emory University School of Medicine, Atlanta (GA), 
USA, 4Servei Pneumologia, Hospital Clínic-IDIBAPS, Barcelona, Spain and 
5Institut de Bioenginyeria de Catalunya, Barcelona, Spain
References
1. McNicholas WT, Bonsignore MR: Sleep apnea as an independent risk 
factor for cardiovascular disease: current evidence, basic mechanisms 
and research priorities.  Eur Respir J 2007, 29:156-178.
2. Tasali E, Ip MS: Obstructive sleep apnea and metabolic syndrome: 
alterations in glucose metabolism and inflammation.  Proc Am Thorac 
Soc 2008, 5:207-217.
3. Levy P, Pepin JL, Arnaud C, Tamisier R, Borel JC, Dematteis M, et al.: 
Intermittent hypoxia and sleep-disordered breathing: current 
concepts and perspectives.  Eur Respir J 2008, 32:1082-1095.
4. Garvey JF, Taylor CT, McNicholas WT: Cardiovascular disease in 
obstructive sleep apnea syndrome: the role of intermittent hypoxia 
and inflammation.  Eur Respir J 2009, 33:1195-1205.
5. Farre R, Montserrat JM, Navajas D: Morbidity due to obstructive sleep 
apnea: insights from animal models.  Curr Opin Pulm Med 2008, 
14:530-536.
6. Prockop DJ: "Stemness" does not explain the repair of many tissues by 
mesenchymal stem/multipotent stromal cells (MSCs).  Clin Pharmacol 
Ther 2007, 82:241-243.
7. Iyler SS, Rojas M: Anti-inflammatory effects of mesenchymal stem cells: 
novel concept for future therapies.  Expert Opin Biol Ther 2008, 8:569-581.
8. Carreras A, Almendros I, Acerbi I, Montserrat JM, Navajas D, Farre R: 
Obstructive apneas induce early release of mesenchymal stem cells 
into circulating blood.  Sleep 2009, 32:117-119.
9. Javazon EH, Colter DC, Schwarz EJ, Prockop DJ: Rat marrow stromal cells 
are more sensitive to plating density and expand more rapidly from 
single-cell-derived colonies than human marrow stromal cells.  Stem 
Cells 2001, 19:219-25.
10. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, et al.: Clinical 
applications of blood-derived and marrow-derived stem cells for 
nonmalignant diseases.  JAMA 2008, 299:925-936.
11. Ukai R, Honmou O, Harada K, Houkin A, Hamada H, Kocsis JD: 
Mesenchymal Stem Cells Derived from Peripheral Blood Protects 
against Ischemia.  J Neurotrauma 2007, 24:508-520.
12. Guo J, Lin GS, Bao CY, Hu ZM, Hu MY: Anti-inflammation role for 
mesenchymal stem cells transplantation in myocardial infarction.  
Inflammation 2007, 30:97-104.
13. Tyndall A, Pistoia V: Mesenchymal stem cells combat sepsis.  Nat Med 
2009, 15:18-20.
14. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL: Bone 
marrow-derived mesenchymal stem cells in repair of the injured lung.  
Am J Respir Cell Mol Biol 2005, 33:145-52.
15. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M: Prevention 
of endotoxin-induced systemic response by bone marrow-derived 
mesenchymal stem cells in mice.  Am J Physiol Lung Cell Mol Physiol 2007, 
293:L131-41.
16. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary 
Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves 
Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice.  
Journal of Immunology 2007, 179:1855-1863.
17. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA: Allogeneic human 
mesenchymal stem cells for treatment of E. coli endotoxin-induced 
acute lung injury in the ex vivo perfused human lung.  Proc Natl Acad 
Sci USA 2009, 106:16357-62.
18. de-la-Pena M, Barcelo A, Barbe F, Pierola J, Pons J, Rimbau E, et al.: 
Endothelial function and circulating endothelial progenitor cells in 
patients with sleep apnea syndrome.  Respiration 2008, 76:28-32.
19. Martin K, Stanchina M, Kouttab N, Harrington EO, Rounds S: Circulating 
endothelial cells and endothelial progenitor cells in obstructive sleep 
apnea.  Lung 2008, 186:145-150.
20. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al.: 
Inflammation, oxidative stress, and repair capacity of the vascular 
endothelium in obstructive sleep apnea.  Circulation 2008, 
117:2270-2278.
21. Farre R, Nacher M, Serrano-Mollar A, Galdiz JB, Alvarez FJ, Navajas D, et al.: 
Rat model of chronic recurrent airway obstructions to study the sleep 
apnea syndrome.  Sleep 2007, 30:930-933.
22. Nacher M, Farre R, Montserrat JM, Torres M, Navajas D, Bulbena O, et al.: 
Biological consequences of oxygen desaturation and respiratory effort 
in an acute animal model of obstructive sleep apnea (OSA).  Sleep Med 
2009, 10:892-897.
23. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, et al.: The 
in vitro migration capacity of human bone marrow mesenchymal stem 
cells: comparison of chemokine and growth factor chemotactic 
activities.  Stem Cells 2007, 25:1737-1745.
24. Segers VF, Van RI, Andries LJ, Lemmens K, Demolder MJ, De Becker AJ, et 
al.: Mesenchymal stem cell adhesion to cardiac microvascular 
endothelium: activators and mechanisms.  Am J Physiol Heart Circ Physiol 
2006, 290:H1370-H1377.
25. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, 
Semenza GL: Expression of vascular endothelial growth factor receptor 
1 in bone marrow-derived mesenchymal cells is dependent on 
hypoxia-inducible factor 1.  J Biol Chem 2006, 281:15554-63.
26. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ: 
Adiponectin inhibits vascular endothelial growth factor-induced 
migration of human coronary artery endothelial cells.  Cardiovasc Res 
2008, 78:376-84.
27. Baumgardner JE, Otto CM: In vitro intermittent hypoxia: challenges for 
creating hypoxia in cell culture.  Respir Physiol Neurobiol 2003, 
136:131-139.
28. Nacher M, Serrano-Mollar A, Farre R, Panes J, Segui J, Montserrat JM: 
Recurrent obstructive apneas trigger early systemic inflammation in a 
rat model of sleep apnea.  Respir Physiol Neurobiol 2007, 155:93-96.
29. Steingen C, Brenig F, Baumgartner L, Schmidt J, Schmidt A, Bloch W: 
Characterization of key mechanisms in transmigration and invasion of 
mesenchymal stem cells.  J Mol Cell Cardiol 2008, 44:1072-1084.
30. Estrada R, Li N, Sarojini H, An J, Lee MJ, Wang E: Secretome from 
mesenchymal stem cells induces angiogenesis via Cyr61.  J Cell Physiol 
2009, 219:563-71.
doi: 10.1186/1465-9921-11-91
Cite this article as: Carreras et al., Obstructive apneas induce early activation 
of mesenchymal stem cells and enhancement of endothelial wound healing 
Respiratory Research 2010, 11:91
Received: 29 March 2010 Accepted: 6 July 2010 
Published: 6 July 2010
This article is available from: http://respiratory-research.com/content/11/1/91© 2010 Carreras et al; licensee BioM d Central Ltd. is an Open Access article distributed under h  terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Resp ratory R se rch 2010, 11:91
